Comparable stake leader
INTRACOASTAL CAPITAL, LLC
SEC ownership of Bone Biologics Corp
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001419554.
Disclosed value leader
Don Hankey
Comparable rows
3/13
Latest evidence
31 Mar 2026
- Public ticker
- BBLG, BBLGW on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
INTRACOASTAL CAPITAL, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
3 of 13
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
INTRACOASTAL CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001419554
- Issuer location
- Burlington, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Bone Biologics Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
INTRACOASTAL CAPITAL, LLC
Disclosed value leader
Don Hankey
Comparable rows
3/13
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 10%
10 rows are not safely comparable across share classes.
13D/G row: INTRACOASTAL CAPITAL, LLC
Showing 1-8 of 13 holder rows.
Quick read
INTRACOASTAL CAPITAL, LLC leads the comparable SEC ownership view at 10%.
3 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens INTRACOASTAL CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 3
INTRACOASTAL CAPITAL, LLC
10%
Tower Research Capital LLC (TRC)
0.21%
SBI Securities Co., Ltd.
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
10%
|
$482,187
199,251 shares
|
+$111,397 | 30 Sep 2025 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.21%
|
$4,539
4,126 shares
|
— | 31 Mar 2026 |
| SBI Securities Co., Ltd. |
13F
Company
|
0.01%
|
$253
230 shares
|
— | 31 Mar 2026 |
| Don Hankey |
3/4/5
Chairman of the Board, Director, 10%+ Owner
|
—
mixed-class rows
|
$4,289,289
7,144,395 shares
mixed-class rows
|
— | 27 Mar 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$684,296
29,752 shares
|
— | 31 Mar 2026 |
| Bruce Stroever |
3/4/5
Director
|
—
class O/S missing
|
$49,057
62,894 shares
|
— | 04 Jun 2025 |
| Phillip Terry Meikle II |
3/4/5
Director
|
—
class O/S missing
|
$49,057
62,894 shares
|
— | 04 Jun 2025 |
| Robert E. Gagnon |
3/4/5
Director
|
—
class O/S missing
|
$49,057
62,894 shares
|
— | 04 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 01 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-8 of 8 reporting-owner rows connected to Bone Biologics Corp. Open a relationship link for the CIK-to-CIK filing trail.
Rows
8
Largest Forms 3/4/5 holder
Don Hankey
Net 12M change
$0
Latest report
08 Jan 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Don Hankey | Chairman of the Board, Director, 10%+ Owner | $4,289,289 | Mixed | 27 Mar 2023 | ||
| Robert E. Gagnon | Director | $49,057 | Mixed | 04 Jun 2025 | ||
| Siddhesh Rajendra Angle | Director | $49,057 | Mixed | 04 Jun 2025 | ||
| Phillip Terry Meikle II | Director | $49,057 | Mixed | 04 Jun 2025 | ||
| Bruce Stroever | Director | $49,057 | Mixed | 04 Jun 2025 | ||
| Jeff Frelick | Chief Executive Officer | $25,882 | Mixed | 08 Jan 2026 | ||
| Deina H. Walsh | Chief Financial Officer | $13,144 | Mixed | 08 Jan 2026 | ||
| Erick Lucera | Director | Mixed | 18 Sep 2023 |
Recent insider transactions for Bone Biologics Corp
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Deina H. Walsh | BBLG | Employee Stock Option | Award | 8,335 | 8,335 | 08 Jan 2026 | Direct | |||
| Jeff Frelick | BBLG | Employee Stock Option | Award | 16,668 | 16,668 | 08 Jan 2026 | Direct |
* marks a reported price that did not pass the local price check.